ERBB2 and breast cancer: Human epidermal growth factor receptor 2 (HER2) positive breast cancer (HER2+ BC), which belongs to a subtype of breast cancer with HER2 gene amplification and HER2 protein overexpression, accounts for about 25%–30% of all breast cancers [4,5].